Dolutegravir-rilpivirine: first 2-drug regimen for HIV-positive adults

Properzi, M; Magro, P; Castelli, F; Quiros-Roldan, E

Castelli, F (reprint author), Univ Brescia, Univ Dept Infect & Trop Dis, Piazzale Spedali Civili 1, I-25123 Brescia, Italy.; Castelli, F (reprint author), ASST Spedali Civili Gen Hosp, Piazzale Spedali Civili 1, I-25123 Brescia, Italy.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2018; 16 (12): 877

Abstract

Introduction: New strategies for HIV treatment are being investigated to reduce drug-exposure, toxicities, and costs. Dolutegravir (DTG) 50 mg/rilpivi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索